Andrea Galbiati

Company: Philochem

Job title: Group Leader

Seminars:

Detailing Clinical Development of OncoFAP: a Small Molecule Conjugate Targeting Fibroblast Activation Protein in Solid Tumours 9:30 am

• Exploring ongoing OncoFAP tumour target activity in first-in-human imaging studies in solid tumours • Assessing OncoFAP anti-tumour response as a monotherapy and in combination with immunotherapies • Contrasting anti-cancer properties of small-molecule conjugates against antibody-drug conjugatesRead more

day: Conference Day Two pt 1